Autoantibody profiles delineate distinct subsets of scleromyositis.

Valérie LeclairJulie D'AoustGeneviève GygerOcéane Landon-CardinalAlain MeyerErin O'FerrallJason KaramchandaniRami MassieBenjamin EllezamMinoru SatohYves TroyanovMarvin J FritzlerMarie Hudsonnull null

Published in: Rheumatology (Oxford, England) (2021)

In this carefully phenotyped series of scleromyositis subjects, absence of SSc-related autoantibodies was common and associated with distinct features and poor prognosis. Future studies are needed to validate these results and possibly identify novel autoantibodies or other biomarkers associated with scleromyositis.

Keyphrases

poor prognosis
long non coding rna
systemic lupus erythematosus
current status
case control
drug induced